NEW YORK, Nov. 10 Reportlinker.com announces that a new market research report is available in its catalogue.
Central Nervous System Insomnia or Sleep Disorders
Advertisement
http://www.reportlinker.com/p0161866/Central-Nervous-System-Insomnia-or-Sleep-Disorders.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire
Advertisement
Life Science Analytics', Central Nervous System Insomnia or Sleep Disorders contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of insomnia or sleep disorders drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
-- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
-- Keep track of your competitors and partners by better understanding their product pipeline.
-- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
-- Maintain a critical competitive advantage.
Epidemiology Report
% of Products by Phase of Development
No. of Products by Phase of Development
Marketed Products vs. Pipeline Products
Company Overview - Pipeline Projects
Legend
--Top 5 Companies in Early Stage Insomnia or Sleep Disorders Products
--Top 5 Companies in Late Stage Insomnia or Sleep Disorders Products
--Top 5 Companies in Marketed Insomnia or Sleep Disorders Products
Patent Expirations
Upcoming Milestones
Product Sales
Full Pipeline View
--Product Details : Unknown/Research
--Product Details : Pre Clinical
--Product Details : Phase I
--Product Details : Phase II
--Product Details : Phase III
--Product Details : Pending Approval
--Product Details : Approved
--Product Details : On the Market
--Product Details : Post Marketing
News Updates
--Intellectual Property
--Product Updates
--Regulatory
To order this report:
Central Nervous System Insomnia or Sleep Disorders
http://www.reportlinker.com/p0161866/Central-Nervous-System-Insomnia-or-Sleep-Disorders.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire
More market research reports here!
Nicolas Bombourg Reportlinker Email: [email protected] US: (805)-652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
